A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy by Victor, RG, Sweeney, HL, Finkel, R, McDonald, CM, Byrne, B, Eagle, M, Goemans, N, Vandenborne, K, Dubrovsky, AL, Topaloglu, H, Miceli, MC, Furlong, P, Landry, J, Elashoff, R, Tadalafil DMD Study Group, Servais, L

Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study by Muntoni, F, Signorovitch, J, Sajeev, G, Done, N, Yao, Z, Goemans, N, McDonald, C, Mercuri, E, Niks, EH, Wong, B, Vandenborne, K, Straub, V, de Groot, IJM, Tian, C, Manzur, A, Dieye, I, Lane, H, Ward, SJ, Servais, L, PRO-DMD-01 study investigators, Association Française contre les Myopathies, The UK NorthStar Clinical Network, ImagingDMD investigators, cTAP